277 related articles for article (PubMed ID: 33429176)
1. Mastoid obliteration with S53P4 bioactive glass after canal wall down mastoidectomy: Preliminary results.
Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
Am J Otolaryngol; 2021; 42(2):102895. PubMed ID: 33429176
[TBL] [Abstract][Full Text] [Related]
2. Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.
Vos J; de Vey Mestdagh P; Colnot D; Borggreven P; Orelio C; Quak J
Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4121-4126. PubMed ID: 28956143
[TBL] [Abstract][Full Text] [Related]
3. Bioglass reconstruction of posterior meatal wall after canal wall down mastoidectomy.
Sorour SS; Mohamed NN; Abdel Fattah MM; Elbary MEA; El-Anwar MW
Am J Otolaryngol; 2018; 39(3):282-285. PubMed ID: 29526381
[TBL] [Abstract][Full Text] [Related]
4. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
Kim CW; Oh JI; Choi KY; Park SM; Park MI
Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
[TBL] [Abstract][Full Text] [Related]
5. Mastoid obliteration combined with soft-wall reconstruction of posterior ear canal.
Takahashi H; Iwanaga T; Kaieda S; Fukuda T; Kumagami H; Takasaki K; Hasebe S; Funabiki K
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):867-71. PubMed ID: 17340129
[TBL] [Abstract][Full Text] [Related]
6. Mastoid Obliteration with Synthetic Materials: A Review of the Literature.
Skoulakis C; Koltsidopoulos P; Iyer A; Kontorinis G
J Int Adv Otol; 2019 Dec; 15(3):400-404. PubMed ID: 31846919
[TBL] [Abstract][Full Text] [Related]
7. Pseudo mastoid obliteration with conchal cartilage may be a safe alternative technique for cochlear implantation in canal wall down mastoidectomy with large meatoplasty.
Carnevale C; Til-Pérez G; Arancibia-Tagle D; Tomás-Barberán M; Sarría-Echegaray P
J Laryngol Otol; 2020 Jun; 134(6):493-496. PubMed ID: 32618542
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of canal wall reconstruction tympanomastoidectomy.
Walker PC; Mowry SE; Hansen MR; Gantz BJ
Otol Neurotol; 2014 Jan; 35(1):e24-30. PubMed ID: 24136324
[TBL] [Abstract][Full Text] [Related]
9. External Auditory Canal Reconstruction and Mastoid Obliteration Using Modified Palva Flap in Canal Wall Down Mastoidectomy With Tympanoplasty.
Kim JS; Lim IG; Oh JH; Kim BG; Chang KH
Ann Otol Rhinol Laryngol; 2019 Jun; 128(6_suppl):69S-75S. PubMed ID: 31092030
[TBL] [Abstract][Full Text] [Related]
10. Implantation of two generations of Bonebridge after mastoid obliteration with bioactive glass S53P4.
Skarzynski PH; Krol B; Skarzynski H; Cywka KB
Am J Otolaryngol; 2022; 43(5):103601. PubMed ID: 35981433
[TBL] [Abstract][Full Text] [Related]
11. Mastoid Obliteration Using S53P4 Bioactive Glass in Cholesteatoma Surgery: A 10-Year Single-Center Experience in 173 Adult Patients with Long-Term Magnetic Resonance Imaging Controlled Follow-up.
Kroon VJ; Mes SW; Borggreven PA; van de Langenberg R; Colnot DR; Quak JJ
Otol Neurotol; 2022 Dec; 43(10):1181-1188. PubMed ID: 36099589
[TBL] [Abstract][Full Text] [Related]
12. Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy.
Ramsey MJ; Merchant SN; McKenna MJ
Otol Neurotol; 2004 Nov; 25(6):873-8. PubMed ID: 15547414
[TBL] [Abstract][Full Text] [Related]
13. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
[TBL] [Abstract][Full Text] [Related]
14. Results of revision mastoidectomy.
Berçin S; Kutluhan A; Bozdemir K; Yalçiner G; Sari N; Karamese O
Acta Otolaryngol; 2009 Feb; 129(2):138-41. PubMed ID: 18607914
[TBL] [Abstract][Full Text] [Related]
15. Alternative to canal wall-down mastoidectomy for sclerotic mastoid cavities: epitympanoplasty with mastoid obliteration.
Heo KW; Kang MK; Park JY
Ann Otol Rhinol Laryngol; 2014 Jan; 123(1):47-52. PubMed ID: 24574423
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of canal wall reconstruction tympanomastoidectomy.
Walker PC; Mowry SE; Hansen MR; Gantz BJ
Otol Neurotol; 2014 Jul; 35(6):954-60. PubMed ID: 25072070
[TBL] [Abstract][Full Text] [Related]
17. Canal wall down approach for tympano-mastoid cholesteatoma: long-term results and prognostic factors.
Pareschi R; Lepera D; Nucci R
Acta Otorhinolaryngol Ital; 2019 Apr; 39(2):122-129. PubMed ID: 31097831
[TBL] [Abstract][Full Text] [Related]
18. Canal wall down mastoidectomy with obliteration versus canal wall up mastoidectomy in primary cholesteatoma surgery.
Wilkie MD; Chudek D; Webb CJ; Panarese A; Banhegyi G
J Laryngol Otol; 2019 Dec; 133(12):1074-1078. PubMed ID: 31735175
[TBL] [Abstract][Full Text] [Related]
19. Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.
Król B; Cywka KB; Skarżyńska MB; Skarżyński PH
Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33921929
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Posterior Canal Wall Reconstruction Using Autologous Auricular Cartilage and Bone Pâté in Chronic Otitis Media with Cholesteatoma.
Baek MK; Choi SH; Kim DY; Cho CH; Kim YW; Moon KH; Lee JH
J Int Adv Otol; 2016 Dec; 12(3):247-251. PubMed ID: 27879225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
